Enlivex Therapeutics Stock Price History

ENLV Stock  USD 0.93  0.09  10.71%   
Below is the normalized historical share price chart for Enlivex Therapeutics extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enlivex Therapeutics stands at 0.93, as last reported on the 25th of November, with the highest price reaching 0.93 and the lowest price hitting 0.83 during the day.
IPO Date
12th of December 1995
200 Day MA
1.8548
50 Day MA
1.3995
Beta
1.105
 
Yuan Drop
 
Covid
If you're considering investing in Enlivex Stock, it is important to understand the factors that can impact its price. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0716, which denotes the company had a -0.0716% return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Standard Deviation of 4.86, mean deviation of 3.33, and Variance of 23.61 to check the risk estimate we provide.
  
At this time, Enlivex Therapeutics' Common Stock is fairly stable compared to the past year. Preferred Stock Total Equity is likely to climb to about 10.2 M in 2024, whereas Treasury Stock is likely to drop (959.2 K) in 2024. . Price To Sales Ratio is likely to drop to 39.01 in 2024. Price Earnings Ratio is likely to drop to -1.81 in 2024. Enlivex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0716

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsENLV

Estimated Market Risk

 4.87
  actual daily
43
57% of assets are more volatile

Expected Return

 -0.35
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Enlivex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enlivex Therapeutics by adding Enlivex Therapeutics to a well-diversified portfolio.
Price Book
0.6965
Book Value
1.368
Enterprise Value
-5.2 M
Enterprise Value Ebitda
(1.49)
Shares Float
15.6 M

Enlivex Therapeutics Stock Price History Chart

There are several ways to analyze Enlivex Stock price data. The simplest method is using a basic Enlivex candlestick price chart, which shows Enlivex Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 16, 20241.69
Lowest PriceNovember 21, 20240.84

Enlivex Therapeutics November 25, 2024 Stock Price Synopsis

Various analyses of Enlivex Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enlivex Stock. It can be used to describe the percentage change in the price of Enlivex Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enlivex Stock.
Enlivex Therapeutics Price Rate Of Daily Change 1.11 
Enlivex Therapeutics Price Daily Balance Of Power 0.90 
Enlivex Therapeutics Price Action Indicator 0.10 

Enlivex Therapeutics November 25, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Enlivex Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Enlivex Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Enlivex Stock and then apply it to test your longer-term investment strategies against Enlivex.

Enlivex Stock Price History Data

The price series of Enlivex Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 0.85 with a coefficient of variation of 14.04. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.37. The median price for the last 90 days is 1.45. The company completed 1:8 stock split on 6th of March 2019. Enlivex Therapeutics completed dividends distribution on 2019-03-06.
OpenHighLowCloseVolume
11/25/2024
 0.83  0.93  0.83  0.93 
11/22/2024 0.83  0.93  0.83  0.93  221,613 
11/21/2024 1.00  1.02  0.81  0.84  427,729 
11/20/2024 1.06  1.11  0.93  0.98  388,174 
11/19/2024 1.03  1.06  1.01  1.03  60,389 
11/18/2024 1.06  1.09  1.00  1.05  198,590 
11/15/2024 1.09  1.10  1.01  1.07  132,493 
11/14/2024 1.16  1.17  1.08  1.08  158,628 
11/13/2024 1.21  1.21  1.13  1.18  116,463 
11/12/2024 1.20  1.23  1.17  1.20  115,147 
11/11/2024 1.27  1.27  1.15  1.20  212,477 
11/08/2024 1.25  1.29  1.21  1.23  92,194 
11/07/2024 1.27  1.31  1.21  1.27  160,967 
11/06/2024 1.31  1.33  1.21  1.27  131,971 
11/05/2024 1.29  1.32  1.24  1.29  144,037 
11/04/2024 1.41  1.43  1.22  1.30  209,368 
11/01/2024 1.35  1.41  1.30  1.36  92,412 
10/31/2024 1.40  1.41  1.27  1.35  270,433 
10/30/2024 1.47  1.47  1.36  1.38  140,332 
10/29/2024 1.45  1.48  1.41  1.43  89,230 
10/28/2024 1.50  1.59  1.43  1.48  162,936 
10/25/2024 1.55  1.65  1.41  1.47  275,489 
10/24/2024 1.60  1.61  1.45  1.52  255,780 
10/23/2024 1.54  1.55  1.45  1.49  288,091 
10/22/2024 1.55  1.58  1.45  1.47  172,757 
10/21/2024 1.62  1.63  1.49  1.53  214,961 
10/18/2024 1.68  1.71  1.51  1.52  173,689 
10/17/2024 1.70  1.71  1.60  1.63  171,201 
10/16/2024 1.63  1.75  1.60  1.69  368,315 
10/15/2024 1.46  1.56  1.45  1.55  74,006 
10/14/2024 1.43  1.52  1.43  1.45  68,378 
10/11/2024 1.47  1.49  1.38  1.46  32,414 
10/10/2024 1.53  1.59  1.43  1.49  45,414 
10/09/2024 1.46  1.56  1.46  1.54  12,923 
10/08/2024 1.53  1.55  1.45  1.48  35,455 
10/07/2024 1.54  1.60  1.48  1.53  32,190 
10/04/2024 1.63  1.63  1.52  1.59  36,310 
10/03/2024 1.55  1.62  1.55  1.58  19,862 
10/02/2024 1.59  1.59  1.55  1.55  31,692 
10/01/2024 1.68  1.69  1.56  1.61  52,401 
09/30/2024 1.62  1.75  1.62  1.68  106,843 
09/27/2024 1.59  1.71  1.58  1.64  196,610 
09/26/2024 1.49  1.60  1.47  1.58  126,457 
09/25/2024 1.50  1.50  1.44  1.46  40,135 
09/24/2024 1.50  1.54  1.40  1.48  77,899 
09/23/2024 1.51  1.52  1.36  1.48  154,582 
09/20/2024 1.55  1.57  1.44  1.51  68,169 
09/19/2024 1.60  1.65  1.45  1.50  298,435 
09/18/2024 1.60  1.74  1.53  1.55  355,721 
09/17/2024 1.57  1.70  1.42  1.51  265,138 
09/16/2024 1.60  1.65  1.50  1.54  182,002 
09/13/2024 1.61  1.76  1.53  1.57  424,491 
09/12/2024 1.34  1.64  1.29  1.59  592,044 
09/11/2024 1.29  1.32  1.26  1.31  107,605 
09/10/2024 1.19  1.27  1.19  1.27  41,746 
09/09/2024 1.20  1.24  1.20  1.20  18,926 
09/06/2024 1.27  1.27  1.22  1.27  4,044 
09/05/2024 1.20  1.23  1.20  1.23  17,003 
09/04/2024 1.24  1.29  1.22  1.23  27,993 
09/03/2024 1.25  1.27  1.22  1.26  17,787 
08/30/2024 1.22  1.30  1.21  1.30  25,699 

About Enlivex Therapeutics Stock history

Enlivex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enlivex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enlivex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enlivex Therapeutics stock prices may prove useful in developing a viable investing in Enlivex Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding18.6 M19.5 M
Net Loss-28 M-26.6 M

Enlivex Therapeutics Quarterly Net Working Capital

25.73 Million

Enlivex Therapeutics Stock Technical Analysis

Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Enlivex Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Enlivex Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Enlivex Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Enlivex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enlivex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enlivex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Enlivex Stock Analysis

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.